Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Efficacy and Safety Study of Tapinarof for the Treatment of Plaque Psoriasis in Adults

NCT03956355 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT03956355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03956355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Efficacy and Safety Study of Tapinarof for the Treatment of Plaque Psoriasis in Adults
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
May 21, 2019
Completion date
May 26, 2020
Enrollment
510 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis